Upregulation of stomatin is associated with poor prognosis and promotes tumor progression of orbital diffuse large B-cell lymphoma
Our findings indicate that stomatin contributes to orbital DLBCL progression and is associated with adverse clinical outcomes. Stomatin may serve as both a prognostic biomarker and a potential therapeutic target for this malignancy.
Authors
- Weichen Song (ORCID: https://orcid.org/0000-0003-3197-6236)
- Wenwen Zhu
- Jingyi Chi (ORCID: https://orcid.org/0000-0001-6013-8544)
- Wen Chen (ORCID: https://orcid.org/0000-0001-9142-5132)
- Xinyu Liu (ORCID: https://orcid.org/0000-0002-5180-6958)
- Li-hua Xiao (ORCID: https://orcid.org/0009-0008-3601-9201)
- Xiuyun Li (ORCID: https://orcid.org/0000-0002-0764-7769)
- Jiaxin Ma (ORCID: https://orcid.org/0000-0002-7429-1205)
Institutions
- Weifang Medical University (CN)
- Chinese PLA General Hospital (CN)
- Second Hospital of Shandong University (CN)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2025-05-23
- DOI
- https://doi.org/10.3389/fonc.2025.1596614
- Primary Topic
- Lymphoma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Natural Science Foundation of Shandong Province